AESKULISA tTg-A New Generation 7503US

GUDID 04250289503129

The AESKULISA tTg-A New generation is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgA antibodies against neo-ep

Aesku.Diagnostics GmbH & Co. KG

Tissue transglutaminase antibody IVD, kit, enzyme immunoassay (EIA)
Primary Device ID04250289503129
NIH Device Record Keye0ec107f-fd7a-4157-bcd9-88ec201f93a4
Commercial Distribution StatusIn Commercial Distribution
Brand NameAESKULISA tTg-A New Generation
Version Model Number7503US
Catalog Number7503US
Company DUNS341714388
Company NameAesku.Diagnostics GmbH & Co. KG
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS104250289503129 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

MVMAutoantibodies, Endomysial(Tissue Transglutaminase)

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number3
Public Version Date2018-07-06
Device Publish Date2017-03-17

On-Brand Devices [AESKULISA tTg-A New Generation ]

04250289503129The AESKULISA tTg-A New generation is a solid phase enzyme immunoassay for the quantitative and
04250289502870The AESKULISA tTg-A New generation is a solid phase enzyme immunoassay for the quantitative and

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.